4.7 Review

Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The Parkinson's disease variant rs356182 regulates neuronal differentiation independently from alpha-synuclein

Jordan D. Prahl et al.

Summary: We discovered a novel risk mechanism for a significant risk variant, rs356182, in Parkinson's disease. The risk allele (G) is associated with abnormal neuron development, independent of SNCA expression, leading to increased susceptibility to Parkinson's disease later in life.

HUMAN MOLECULAR GENETICS (2023)

Review Neurosciences

α-Synuclein and Mechanisms of Epigenetic Regulation

Andrei Surguchov

Summary: Synucleinopathies are neurodegenerative diseases characterized by excessive accumulation and abnormal deposition of alpha-synuclein, leading to motor, cognitive, and behavioral decline. Research is ongoing to find disease-modifying treatments and early diagnostic markers. Alpha-synuclein is involved in epigenetic regulation through binding to DNA and histones, controlling gene transcription. This article discusses the role of alpha-synuclein in epigenetic regulation in health and disease.

BRAIN SCIENCES (2023)

Article Genetics & Heredity

Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression

Alise Zagare et al.

Summary: Human brain organoids are a valuable tool for studying neurodegenerative diseases like Parkinson's disease. This study shows that the in vitro model of human midbrain organoids accurately recapitulates the developmental path and cellular composition of the in vivo midbrain. The researchers also discovered that a specific genetic variant affects neurodevelopment and identified potential candidate genes associated with this variant.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Article Neurosciences

Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1α expression in PC12 cells

Yi Zhang et al.

Summary: In this study, the role of short-chain fatty acids (SCFAs) in rat dopaminergic PC12 cells treated with rotenone was investigated, and the potential mechanisms underlying the expression of PGC-1 alpha were explored. The results showed that sodium butyrate (NaB) protected cells against rotenone-induced toxicity by activating the autophagy pathway and reducing the expression of alpha-synuclein. Notably, NaB activated the autophagy pathway by upregulating PGC-1 alpha expression and promoting histone acetylation modification at the PGC-1 alpha promoter region.

BRAIN RESEARCH (2022)

Article Biochemistry & Molecular Biology

Senescence and impaired DNA damage responses in alpha-synucleinopathy models

Ye-Seul Yoon et al.

Summary: Excessive expression of Parkinson's protein impairs DNA repair and leads to cellular senescence. The accumulation of DNA double-strand breaks and cellular senescence are intermediaries of alpha-synuclein-induced pathogenesis in Parkinson's disease.

EXPERIMENTAL AND MOLECULAR MEDICINE (2022)

Article Biochemistry & Molecular Biology

Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties

Sydney E. Dent et al.

Summary: In this study, we found that both alpha-synuclein (aSyn) and its phosphorylated form (pSyn) can bind DNA in a DNA length-dependent manner, but without specificity for DNA sequence. We also observed that the phosphorylation of serine-129 reduces the ability of aSyn to bind and bend DNA. These findings suggest that the ability of aSyn to interact with DNA and modulate DNA metabolism may be regulated by phosphorylation.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Clinical Neurology

Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment

Javier Jarazo et al.

Summary: This study investigated the differences between neurons derived from Parkinson's disease patients and controls, identifying potential pathways for targeted treatment. By correcting mutations and using a specific compound, improvements in metabolic properties and neuronal differentiation in patient-derived cells were observed. Treatment with a repurposed compound was shown to restore impaired dopaminergic differentiation in Parkinson's disease patient-derived cells.

MOVEMENT DISORDERS (2022)

Review Cell Biology

Modulation of cellular processes by histone and non-histone protein acetylation

Maria Shvedunova et al.

Summary: Lysine acetylation is a crucial protein post-translational modification that plays important roles in cellular and physiological processes. Lysine acetyltransferases and lysine deacetylases regulate gene expression and protein function by controlling acetylation and deacetylation.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Biology

DNA Methylation: A Promising Approach in Management of Alzheimer's Disease and Other Neurodegenerative Disorders

Gagandeep Kaur et al.

Summary: This study summarizes the role of DNA methylation in neurodevelopment and neurodegenerative diseases, as well as its potential as a biomarker and therapeutic tool.

BIOLOGY-BASEL (2022)

Article Biochemistry & Molecular Biology

Characterization of the class IIa histone deacetylases substrate specificity

Zsofia Kutil et al.

Summary: In this study, the researchers designed and synthesized a peptide library to investigate the substrate specificity of Class IIa histone deacetylases (HDACs). The results showed a strong preference for aromatic acids flanking the central modified lysine, while positively charged residues and proline were disfavored at specific positions. The chemical nature of amino acid residues N-terminally to the modified lysine had a greater impact on substrate recognition than residues located C-terminally.

FASEB JOURNAL (2022)

Article Biochemistry & Molecular Biology

Alpha-synuclein overexpression induces epigenomic dysregulation of glutamate signaling and locomotor pathways

Samantha L. Schaffner et al.

Summary: This study identified the association between alpha-synuclein variants and epigenetic regulation of PD, impacting DNA methylation at thousands of CpGs and DNA hydroxymethylation at hundreds of CpGs, primarily involving genes related to locomotor behavior and glutamate signaling pathways.

HUMAN MOLECULAR GENETICS (2022)

Review Biochemistry & Molecular Biology

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies

Ichiro Kawahata et al.

Summary: alpha-Synuclein is a protein associated with Parkinson's disease, and its phosphorylation and aggregation play a crucial role in disease pathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Neurons with Cat's Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions

Francesca De Giorgi et al.

Summary: The distinct neuropathological features and inclusion bodies in different alpha-Synucleinopathies reflect the strain diversity of invasive alpha-Syn amyloids. However, the contribution of non-amyloid factors to specific diseases is still uncertain. In Multiple System Atrophy, alpha-Syn inclusions in oligodendrocytes seem to result from the storage of amyloid aggregates pre-assembled in neurons. These inclusions originate from unique molecular properties or other factors dysregulated in MSA.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

Aggregated Alpha-Synuclein Inclusions within the Nucleus Predict Impending Neuronal Cell Death in a Mouse Model of Parkinsonism

Leah J. Weston et al.

Summary: Intranuclear aggregation of alpha-synuclein (aSyn) may occur through transmission between neurons, and this process could contribute to neurodegeneration in synucleinopathies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability

Erinc Hallacli et al.

Summary: This study reveals the direct modulation of processing bodies by alpha-synuclein, which has significant implications for understanding the pathogenesis of Parkinson's disease. The research found that alpha-synuclein disrupts mRNA decay through interacting with multiple proteins, leading to the dysfunction of relevant pathways. Genetic modulation of P-body components can alter the toxicity of alpha-synuclein, providing a new direction for disease treatment.
Article Clinical Neurology

Methylation of alpha-synuclein in a Sudanese cohort

Yousuf Bakhit et al.

Summary: After studying several Parkinson's disease patients in Sudan, the team discovered a specific pattern of DNA methylation that plays a crucial role in the occurrence of familial Parkinson's disease.

PARKINSONISM & RELATED DISORDERS (2022)

Article Cell Biology

Recognition of the TDP-43 nuclear localization signal by importin α1/β

Steven G. Doll et al.

Summary: This study investigates the interaction between the bipartite nuclear localization signal (NLS) of TDP-43 and importin alpha 1/beta. The study finds that the NLS has extensive contacts with importin alpha 1, particularly at a minor NLS-binding site, disrupting the N-terminal domain (NTD) dimerization interface of TDP-43. A potential phosphorylation site near TDP-43 R83 at the minor NLS site reduces binding to importins by affecting the dynamics of the NLS backbone.

CELL REPORTS (2022)

Article Geriatrics & Gerontology

Gut metabolite trimethylamine N-oxide induces aging-associated phenotype of midbrain organoids for the induced pluripotent stem cell-based modeling of late-onset disease

Youngsun Lee et al.

Summary: Brain organoids are valuable models for studying human brain development and disease. This study investigated the association between the gut metabolite TMAO and aging, and found that TMAO can induce aging-associated molecular changes and neurodegeneration phenotypes in midbrain organoids. These findings provide insight into the role of TMAO in midbrain aging and pathogenesis, and highlight the importance of intestinal dysfunction in increasing the risk of Parkinson's disease.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation

Katharina Pieger et al.

Summary: This study identified distinct nuclear and cytosolic species of aSyn and revealed their redistribution during neuronal differentiation. Furthermore, a different distribution pattern of aSyn was observed in cells from PD patients carrying aSyn gene duplication.

BIOMOLECULES (2022)

Article Developmental Biology

Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain

Marcella Birtele et al.

Summary: This study used single-cell RNA sequencing to analyze the transcriptional profile of human fetal VM during the generation and differentiation of dopamine neurons, revealing that 3D culture conditions are superior to monolayer conditions. These findings can guide stem cell-based therapies and disease modeling in Parkinson's disease.

DEVELOPMENT (2022)

Article Geriatrics & Gerontology

Integrative analysis of DNA methylation and gene expression data for the diagnosis and underlying mechanism of Parkinson's disease

Ding Li et al.

Summary: This study aimed to construct a methylation-driven genes signature and a methylation-altered CpGs signature for the diagnosis of Parkinson's disease (PD), based on integrated analysis of DNA methylation and gene expression data. Both signatures showed robust prediction power and provided new insights into personalized diagnostic and therapeutic strategies for PD.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Review Genetics & Heredity

DNA methylation as a mediator of genetic and environmental influences on Parkinson's disease susceptibility: Impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome

Samantha L. L. Schaffner et al.

Summary: This narrative review provides an overview of the genetic and environmental factors contributing to Parkinson's disease (PD) risk, with a focus on the role of cytosine methylation and hydroxymethylation as potential early-stage biomarkers. The review highlights the impact of variants in the SNCA gene, exposure to pesticides, and physical activity on the epigenome, particularly at the level of CpG methylation. It also discusses the emerging evidence for interaction effects between genetic and environmental contributions to PD risk. The review suggests that future epigenetics studies of PD should build upon existing foundations and utilize large datasets, new technologies, and relevant statistical approaches to further elucidate the etiology of this disease.

FRONTIERS IN GENETICS (2022)

Article Cell Biology

Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids

Jia Shang et al.

Summary: This study investigated the effects of sevoflurane on the midbrain's development using human physiologically-relevant midbrain organoids. The results showed that long-term exposure to sevoflurane could promote premature differentiation of midbrain organoids and inhibit cell proliferation, indicating a potential adverse effect on the midbrain development in fetuses.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Biochemistry & Molecular Biology

The role of histone modifications: from neurodevelopment to neurodiseases

Jisu Park et al.

Summary: Epigenetic regulatory mechanisms, such as histone modifications, play critical roles in fine-tuning gene expressions during neurogenesis, and aberrant modifications contribute to neurodegenerative and neuropsychiatric diseases.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Genetics & Heredity

COMPASS and SWI/SNF complexes in development and disease

Bercin K. Cenik et al.

Summary: Trithorax group proteins, including COMPASS histone H3 lysine 4 methyltransferase complexes and SWI/SNF chromatin remodelling complexes, play crucial roles in gene regulation, development, and disease. Misregulation of these complexes through genetic abnormalities can lead to pathologies such as developmental disorders and malignancies.

NATURE REVIEWS GENETICS (2021)

Article Cell Biology

α-Synuclein antisense transcript SNCA-AS1 regulates synapses- and aging-related genes suggesting its implication in Parkinson's disease

Federica Rey et al.

Summary: This study characterizes the role of SNCA-AS1 in cellular processes, showing its specific modulation of synaptogenesis and cellular senescence through the regulation of SNCA. The implication of SNCA-AS1 in Parkinson's disease and aging-related processes is highlighted, suggesting its potential as a key player in cellular senescence and with implications for aging-related diseases.

AGING CELL (2021)

Article Medicine, Research & Experimental

Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's disease

Subhrangshu Guhathakurta et al.

Summary: The epigenetic deregulation of alpha-synuclein, indicated by elevated H3K4me3 at the SNCA promoter in the substantia nigra of Parkinson's disease patients, can be diminished by a CRISPR/dCas9-based demethylating system. This study suggests that modulation of the histone landscape of SNCA can decrease alpha-synuclein expression in Parkinson's disease.

EMBO MOLECULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies

Leah J. Weston et al.

Summary: PLK2 is a potential Lewy body kinase, and its deletion reduces the phosphorylation level of α-synuclein at presynaptic terminals but has no effect on phosphorylation levels in Lewy bodies. Inhibition of PLK2 shows promise in developing new therapeutics, yet the mechanism of neuroprotection through PLK2 inhibition is unlikely due to reducing α-synuclein phosphorylation. The true Lewy body kinase still awaits discovery.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids

Alessandro Fiorenzano et al.

Summary: 3D brain organoids have been used as a model system to study human brain development and pathology. Authors established human ventral midbrain organoids and used single cell sequencing to study dopamine neurons. Silk scaffolding was used to generate bioengineered brain organoids that reproduced key molecular aspects of dopamine neurogenesis and reduced variability.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1

Jonas Walter et al.

Summary: Research has shown that the LRRK2-G2019S mutation associated with Parkinson's disease accelerates the differentiation of dopaminergic neurons, leading to an increase in cell death. The key transcription factor NR2F1 plays a role in this pathogenic mechanism by regulating the dynamics of dopaminergic differentiation.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons

Sarah J. Brown et al.

Summary: Recent evidence suggests that neurogenesis continues throughout life but the impact on neurodegenerative disorders like Parkinson's disease is still unclear. Studies in zebrafish and human organoids show that PINK1 deficiency impairs adult dopaminergic neurogenesis, potentially affecting future therapeutic approaches for PD patients with biallelic PINK1 mutations.

SCIENTIFIC REPORTS (2021)

Article Neurosciences

Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains

Jeffrey Gu et al.

Summary: Our study suggests cell-type specific differential DNA methylation within the SNCA intron 1 CGI in PD and DLB patients, which may impact SNCA dysregulation and disease-specific risk. These findings have potential implications for developing targeted therapies for synucleinopathies associated with SNCA dysregulation.

FRONTIERS IN NEUROSCIENCE (2021)

Review Genetics & Heredity

The Role of Histone Lysine Methylation in the Response of Mammalian Cells to Ionizing Radiation

Elena Di Nisio et al.

Summary: This review article explores the role of histone lysine methylation changes in regulating the response to radiation-induced genotoxic damage in mammalian cells. It also discusses the effects of histone methyltransferases (HMTs) and histone demethylases (HDMs) on radio-sensitivity of different cell lines, and provides a bioinformatic analysis of mRNA levels of known HMTs and HDMs under different irradiation conditions.

FRONTIERS IN GENETICS (2021)

Article Clinical Neurology

Lewy Body-like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and alpha-Synuclein Mutations

Junghyun Jo et al.

Summary: Utilizing human midbrain-like organoids (hMLOs), researchers successfully recapitulated the pathologies of Parkinson disease, demonstrating the formation of Lewy body-like structures due to glucocerebrosidase deficiency and wild-type alpha-synuclein overexpression. This provides a promising model for further elucidating the mechanisms of progressive Lewy body formation in Parkinson disease.

ANNALS OF NEUROLOGY (2021)

Review Biochemistry & Molecular Biology

Histone acylations and chromatin dynamics: concepts, challenges, and links to metabolism

Sandra Nitsch et al.

Summary: Post-translational modifications of histone proteins can alter chromatin architecture and gene expression. Cellular metabolites can affect histone acylations, linking cell metabolism with chromatin structure and cellular adaptation. However, technical challenges currently hinder a full understanding of the impact of these modifications on chromatin dynamics.

EMBO REPORTS (2021)

Article Biochemistry & Molecular Biology

α-Synuclein A53T Binds to Transcriptional Adapter 2-Alpha and Blocks Histone H3 Acetylation

Ji-Yeong Lee et al.

Summary: The interaction between alpha-syn A53T and TADA2a may lead to changes in histone modification, which are associated with neurotoxicity in the pathology of PD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Alpha-Synuclein-induced DNA Methylation and Gene Expression in Microglia

Brett A. McGregor et al.

Summary: Synucleinopathy disorders are characterized by the aggregation of a-synuclein in microglia, leading to neuroinflammatory responses. Gene expression and DNA methylation changes induced by a-syn aggregation were observed in microglia, with alterations in adhesion, migration, immune response, and metabolism pathways. The study suggests that a-syn overexpression activates microglia, resulting in neuroinflammation and cellular metabolic stresses, which may contribute to disease progression.

NEUROSCIENCE (2021)

Review Neurosciences

Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment

Seung Won Kim et al.

Summary: The study successfully generated midbrain organoids from human pluripotent stem cells for preparing cells for Parkinson's disease therapy. These cells exhibited stable midbrain characteristics with low batch-to-batch variations, showing potential for clinical application due to their therapeutic capacities.

PROGRESS IN NEUROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Molecular insights into α-synuclein interaction with individual human core histones, linker histone, and dsDNA

Sneha Jos et al.

Summary: The study reveals the role of alpha-Synuclein in Parkinson's disease through specific binding to histones, with the phosphorylation mimicking mutant showing higher affinity for proteins involved in Lewy body formation. The interaction with dsDNA was found to be weak and nonspecific. This suggests that alpha-Synuclein's nuclear function may be driven through histone interaction.

PROTEIN SCIENCE (2021)

Article Multidisciplinary Sciences

Phenotypic manifestation of α-synuclein strains derived from Parkinson's disease and multiple system atrophy in human dopaminergic neurons

Benedict Tanudjojo et al.

Summary: Alpha-synuclein plays a critical role in the pathogenesis of Parkinson's disease and related disorders, causing degeneration of human dopaminergic neurons. The toxicity of alpha-synuclein strains depends on aggregate burden, determined by monomer levels and conformation, and influenced by differential interactomes. Parkinson's disease-associated genes influence the phenotypic manifestation of strains in human neurons.

NATURE COMMUNICATIONS (2021)

Review Genetics & Heredity

Roles for α-Synuclein in Gene Expression

Mahalakshmi Somayaji et al.

Summary: Alpha-Synuclein is a small cytosolic protein associated with various cellular compartments and plays a central role in both sporadic and familial Parkinson's disease. Strategies to decrease its levels in PD patients have been proposed, but potential side effects and normal functions of alpha-Syn need to be carefully evaluated. Recent evidence suggests that alpha-Syn is involved in regulating activity-dependent signal transduction and gene expression pathways fundamental to synaptic plasticity.

GENES (2021)

Review Genetics & Heredity

The Genetics of Parkinson's Disease and Implications for Clinical Practice

Jacob Oliver Day et al.

Summary: The genetic landscape of Parkinson's disease includes rare high penetrance pathogenic variants, genetic risk factor variants, and high frequency, low penetrance variants which contribute to the risk of developing the disease. Understanding these influences can have a major impact on the clinical care of PD patients.

GENES (2021)

Article Neurosciences

In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition

Min Lin et al.

Summary: Pathophysiological changes in dopamine neurons caused by overexpression of alpha-synuclein lead to dysfunction of D2 receptors, resulting in aberrant firing activity, dopamine release, and neuronal morphology, which can be partially restored by D2 receptor agonists such as quinpirole.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Review Neurosciences

A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease

Camilla Christina Pedersen et al.

Summary: There is significant heterogeneity in the clinical presentation and disease progression of patients with Parkinson's disease (PD). Although genetic variants in the SNCA gene region may have some impact on clinical outcomes in PD, they may not be a major factor contributing to the clinical heterogeneity observed in PD.

NPJ PARKINSONS DISEASE (2021)

Article Clinical Neurology

Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy

Nguyen-Vi Mohamed et al.

Summary: This study used three-dimensional midbrain organoids differentiated from human-induced pluripotent stem cells to recapitulate key features of alpha-synuclein pathology in patients with synucleinopathies. The SNCA triplication human midbrain organoids express elevated levels of alpha-synuclein and exhibit an age-dependent increase in alpha-synuclein aggregation, providing a powerful system to study the pathogenesis of synucleinopathies.

BRAIN COMMUNICATIONS (2021)

Article Biochemical Research Methods

Protocol High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells

Lily Sarrafha et al.

Summary: This study presents a high-throughput 3D differentiation protocol for deriving midbrain dopaminergic neurons from human pluripotent stem cells, which allows for large-scale production of uniform midbrain organoids for disease modeling and dopaminergic neuron sorting. The long-term maturing organoid cultures can serve as a model for the entire midbrain.

STAR PROTOCOLS (2021)

Article Biochemical Research Methods

A robust protocol for the generation of human midbrain organoids

Alise Zagare et al.

Summary: The lack of advanced in vitro models recapitulating the human brain complexity is a major obstacle in brain development and neurological disease research. This study presents a robust protocol to derive human midbrain organoids from neuroepithelial stem cells, providing complex 3D models with functional neurons, including dopaminergic neurons and glial cells, making them particularly attractive for the study of Parkinson disease.

STAR PROTOCOLS (2021)

Review Cardiac & Cardiovascular Systems

Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease

Peng Li et al.

NATURE REVIEWS CARDIOLOGY (2020)

Article Biochemistry & Molecular Biology

Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease

Paula Chlebanowska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Geriatrics & Gerontology

Emerging Role of Sirtuin 2 in Parkinson's Disease

Yumei Liu et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Multidisciplinary Sciences

Dopaminylation of histone H3 inventral tegmental area regulates cocaine seeking

Ashley E. Lepack et al.

SCIENCE (2020)

Review Pharmacology & Pharmacy

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation

Surabhi Shukla et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Cell Biology

Midbrain Organoids: A New Tool to Investigate Parkinson's Disease

Lisa Maria Smits et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Clinical Neurology

Machine learning-assisted neurotoxicity prediction in human midbrain organoids

Anna S. Monzel et al.

PARKINSONISM & RELATED DISORDERS (2020)

Article Neurosciences

Brainstem Organoids From Human Pluripotent Stem Cells

Nobuyuki Eura et al.

FRONTIERS IN NEUROSCIENCE (2020)

Review Biochemical Research Methods

From cell lines to pluripotent stem cells for modelling Parkinson's Disease

Elena Ferrari et al.

JOURNAL OF NEUROSCIENCE METHODS (2020)

Article Cell & Tissue Engineering

Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease

Sarah Louise Nickels et al.

STEM CELL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Carbon Fibers as a New Type of Scaffold for Midbrain Organoid Development

Anna Tejchman et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

A dual role for a-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo

Mahalakshmi Somayaji et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Neurosciences

Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations

Masayoshi Kano et al.

NPJ PARKINSONS DISEASE (2020)

Article Biochemistry & Molecular Biology

Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein

Raquel Pinho et al.

HUMAN MOLECULAR GENETICS (2019)

Article Biochemistry & Molecular Biology

The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease

Ian F. Harrison et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Article Multidisciplinary Sciences

Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3

Lorna A. Farrelly et al.

NATURE (2019)

Article Cell & Tissue Engineering

Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids

Hongwon Kim et al.

STEM CELL REPORTS (2019)

Review Biochemistry & Molecular Biology

The physiological role of α-synuclein and its relationship to Parkinson's Disease

David Sulzer et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Article Clinical Neurology

SNCA Rep1 promoter variability influences cognition in Parkinson's disease

Adeline S. L. Ng et al.

MOVEMENT DISORDERS (2019)

Article Multidisciplinary Sciences

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders

Allison J. Schaser et al.

SCIENTIFIC REPORTS (2019)

Editorial Material Neurosciences

Protein-DNA interaction: One step closer to understanding the mechanism of neurodegeneration

Andrei Surguchov

JOURNAL OF NEUROSCIENCE RESEARCH (2019)

Article Biochemistry & Molecular Biology

Sumoylated -synuclein translocates into the nucleus by karyopherin 6

Seungjin Ryu et al.

MOLECULAR & CELLULAR TOXICOLOGY (2019)

Article Neurosciences

Modeling Parkinson's disease in midbrain-like organoids

Lisa M. Smits et al.

NPJ PARKINSONS DISEASE (2019)

Review Genetics & Heredity

The DNA methyltransferase family: a versatile toolkit for epigenetic regulation

Frank Lyko

NATURE REVIEWS GENETICS (2018)

Article Biochemistry & Molecular Biology

Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites

Takuya Yoshizawa et al.

Article Neurosciences

Environmental Enrichment Prevents Transcriptional Disturbances Induced by Alpha-Synuclein Overexpression

Zinah Wassouf et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Article Clinical Neurology

A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease

Lasse Pihlstrom et al.

ANNALS OF NEUROLOGY (2018)

Article Biochemical Research Methods

Millifluidic culture improves human midbrain organoid vitality and differentiation

Emanuel Berger et al.

LAB ON A CHIP (2018)

Article Biochemistry & Molecular Biology

Neurodegenerative Disease Proteinopathies Are Connected to Distinct Histone Post-translational Modification Landscapes

Karen Chen et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Article Clinical Neurology

Histones facilitate α-synuclein aggregation during neuronal apoptosis

Peizhou Jiang et al.

ACTA NEUROPATHOLOGICA (2017)

Article Clinical Neurology

DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies

Yu Funahashi et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2017)

Article Biochemistry & Molecular Biology

Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage

Isabel Paiva et al.

HUMAN MOLECULAR GENETICS (2017)

Review Biochemistry & Molecular Biology

Arginine Methylation: The Coming of Age

Romeo S. Blanc et al.

MOLECULAR CELL (2017)

Review Neurosciences

The SH-SY5Y cell line in Parkinson's disease research: a systematic review

Helena Xicoy et al.

MOLECULAR NEURODEGENERATION (2017)

Review Genetics & Heredity

TET-mediated active DNA demethylation: mechanism, function and beyond

Xiaoji Wu et al.

NATURE REVIEWS GENETICS (2017)

Article Neurosciences

Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease

Subhrangshu Guhathakurta et al.

MOLECULAR BRAIN (2017)

Article Neurosciences

Implications of DNA Methylation in Parkinson's Disease

Ernesto Miranda-Morales et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)

Article Cell & Tissue Engineering

Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells

Anna S. Monzel et al.

STEM CELL REPORTS (2017)

Article Biochemistry & Molecular Biology

Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure

Xuyu Qian et al.

Article Cell Biology

Simple rules for passive diffusion through the nuclear pore complex

Benjamin L. Timney et al.

JOURNAL OF CELL BIOLOGY (2016)

Review Biochemistry & Molecular Biology

DNA methylation in Parkinson's disease

Ullrich Wuellner et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Multidisciplinary Sciences

α-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses

Naoto Sugeno et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

Nicole Stopa et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2015)

Article Developmental Biology

How to make a midbrain dopaminergic neuron

Ernest Arenas et al.

DEVELOPMENT (2015)

Article Geriatrics & Gerontology

DNA methylation levels of α-synuclein intron 1 in the aging brain

Laura de Boni et al.

NEUROBIOLOGY OF AGING (2015)

Article Biochemistry & Molecular Biology

Lys-63-linked Ubiquitination by E3 Ubiquitin Ligase Nedd4-1 Facilitates Endosomal Sequestration of Internalized α-Synuclein

Naoto Sugeno et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Clinical Neurology

Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease

San-xi Ai et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)

Article Clinical Neurology

Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients

Yu-yan Tan et al.

PARKINSONISM & RELATED DISORDERS (2014)

Article Clinical Neurology

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Katerina Markopoulou et al.

PARKINSONISM & RELATED DISORDERS (2014)

Article Cell & Tissue Engineering

Engineering of Midbrain Organoids Containing Long-Lived Dopaminergic Neurons

Vannary Tieng et al.

STEM CELLS AND DEVELOPMENT (2014)

Article Biochemistry & Molecular Biology

α-Synuclein Induces Alterations in Adult Neurogenesis in Parkinson Disease Models via p53-mediated Repression of Notch1

Paula Desplats et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Review Cell Biology

New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?

Karolin Luger et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Article Pharmacology & Pharmacy

New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders

P. Vasudevaraju et al.

JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2012)

Article Biochemistry & Molecular Biology

α-Synuclein Sequesters Dnmt1 from the Nucleus A NOVEL MECHANISM FOR EPIGENETIC ALTERATIONS IN LEWY BODY DISEASES

Paula Desplats et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

Michael J. Devine et al.

NATURE COMMUNICATIONS (2011)

Article Biochemistry & Molecular Biology

DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease

Muralidhar L. Hegde et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2010)

Article Multidisciplinary Sciences

α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

Jacqueline Burre et al.

SCIENCE (2010)

Article Cell Biology

PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease

Bin Zheng et al.

SCIENCE TRANSLATIONAL MEDICINE (2010)

Article Multidisciplinary Sciences

An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network

Lena Ho et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

Serine 129 phosphorylation of α-synuclein induces unfolded protein response-mediated cell death

Naoto Sugeno et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally

Yu Zhang et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Review Biochemistry & Molecular Biology

Parkinson's disease

Bobby Thomas et al.

HUMAN MOLECULAR GENETICS (2007)

Article Multidisciplinary Sciences

Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease

Tiago Fleming Outeiro et al.

SCIENCE (2007)

Article Biochemistry & Molecular Biology

α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Eirene Kontopoulos et al.

HUMAN MOLECULAR GENETICS (2006)

Article Clinical Neurology

Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients

Ornit Chiba-Falek et al.

MOVEMENT DISORDERS (2006)

Article Clinical Neurology

Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications

M Farrer et al.

ANNALS OF NEUROLOGY (2004)

Article Multidisciplinary Sciences

α-synuclein locus triplication causes Parkinson's disease

AB Singleton et al.

SCIENCE (2003)

Article Biochemistry & Molecular Biology

Nuclear localization of α-synuclein and its interaction with histones

J Goers et al.

BIOCHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5

S Chawla et al.

JOURNAL OF NEUROCHEMISTRY (2003)